Do you proactively convert stable kidney transplant recipients from twice-daily immediate release tacrolimus to once-daily extended release tacrolimus to improve long-term adherence?

Yes, we convert to once-daily tacrolimus whenever possible. If we cannot get insurance approval, we work with our pharmacy and the company to try to get the medication for the patient. We expect improved adherence and fewer side effects (due to lack of peak level) for our patients.